Abstract
The right ventricle (RV) is vulnerable during and after heart transplantation. The donor heart goes through a series of events during procurement and implantation which can contribute to right heart failure (RHF). The four main physiologic insults are brainstem death of the donor, hypothermic ischemia during transportation, warm ischemia during surgery and reperfusion injury upon release of the cross-clamp. Recipients with pre-existing pulmonary hypertension are at highest risk of postoperative RHF. RHF typically occurs due to decreased contractility, increased preload or increased afterload during transplantation. The RV is susceptible to periprocedural myocardial strain, ischemia, cardioplegia and surgical trauma as well as hyperacute rejection and pulmonary emboli. In order to detect RHF and determine the etiology, invasive hemodynamic monitoring is required as well as advanced echocardiographic imaging. The management of acute RHF involves preload optimization, hemodynamic stabilization, maintenance of sinus rhythm and atrioventricular synchrony, and ventilatory support. Mechanical support is important in the setting of refractory RHF and needs to be instituted early on if there is poor response to medical therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
D’Alessandro C, et al. Predictive risk factors for primary graft failure requiring temporary extra-corporeal membrane oxygenation support after cardiac transplantation in adults. Eur J Cardiothorac Surg. 2011;40(4):962–9.
D’Ancona G, et al. Primary graft failure after heart transplantation: the importance of donor pharmacological management. Transplant Proc. 2010;42(3):710–2.
Marasco SF, et al. Impact of warm ischemia time on survival after heart transplantation. Transplant Proc. 2012;44(5):1385–9.
Russo MJ, et al. Factors associated with primary graft failure after heart transplantation. Transplantation. 2010;90(4):444–50.
Segovia J, et al. RADIAL: a novel primary graft failure risk score in heart transplantation. J Heart Lung Transplant. 2011;30(6):644–51.
Kobashigawa J, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant. 2014;33(4):327–40.
Cosio Carmena MD, et al. Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk score. J Heart Lung Transplant. 2013;32(12):1187–95.
Chen EP, et al. Right ventricular adaptation to increased afterload after orthotopic cardiac transplantation in the setting of recipient chronic pulmonary hypertension. Circulation. 1997;96(9 Suppl):Ii-141–7.
Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19(1):48–54.
Klima U, et al. Severe right heart failure after heart transplantation. A single-center experience. Transpl Int. 2005;18(3):326–32.
Bittner HB, et al. Brain death alters cardiopulmonary hemodynamics and impairs right ventricular power reserve against an elevation of pulmonary vascular resistance. Chest. 1997;111(3):706–11.
Koch A, et al. Capillary endothelia and cardiomyocytes differ in vulnerability to ischemia/reperfusion during clinical heart transplantation. Eur J Cardiothorac Surg. 2001;20(5):996–1001.
Saito S, et al. Successful treatment of cardiogenic shock caused by humoral cardiac allograft rejection. Circ J. 2009;73(5):970–3.
Weil R 3rd, et al. Hyperacute rejection of a transplanted human heart. Transplantation. 1981;32(1):71–2.
Alvarez-Alvarez RJ, et al. Venous thromboembolism in heart transplant recipients: incidence, recurrence and predisposing factors. J Heart Lung Transplant. 2015;34(2):167–74.
Elboudwarej O, et al. Risk of deep vein thrombosis and pulmonary embolism after heart transplantation: clinical outcomes comparing upper extremity deep vein thrombosis and lower extremity deep vein thrombosis. Clin Transpl. 2015;29(7):629–35.
Costanzo MR, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914–56.
Campbell P, et al. Mismatch of right- and left-sided filling pressures in chronic heart failure. J Card Fail. 2011;17(7):561–8.
Drazner MH, et al. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant. 1999;18(11):1126–32.
Guyton AC, Lindsey AW, Gilluly JJ. The limits of right ventricular compensation following acute increase in pulmonary circulatory resistance. Circ Res. 1954;2(4):326–32.
Erickson KW, et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant. 1990;9(5):526–37.
Griepp RB, et al. Determinants of operative risk in human heart transplantation. Am J Surg. 1971;122(2):192–7.
Kirklin JK, et al. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 1988;7(5):331–6.
Kirklin JK, et al. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol. 1988;11(5):917–24.
Butler J, et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant. 2005;24(2):170–7.
Chen JM, et al. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg. 1997;114(4):627–34.
Korabathina R, et al. The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction. Catheter Cardiovasc Interv. 2012;80(4):593–600.
Truby LK, et al. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2018;37(12):1433–42.
Kobashigawa JA. Clinical guide to heart transplantation. Cham: Springer; 2017.
Shivalkar B, et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation. 1993;87(1):230–9.
Jahania MS, et al. Acute allograft failure in thoracic organ transplantation. J Card Surg. 2000;15(2):122–8.
Novitzky D, Rose AG, Cooper DK. Injury of myocardial conduction tissue and coronary artery smooth muscle following brain death in the baboon. Transplantation. 1988;45(5):964–6.
Ryan JB, et al. Functional evidence of reversible ischemic injury immediately after the sympathetic storm associated with experimental brain death. J Heart Lung Transplant. 2003;22(8):922–8.
Novitzky D, et al. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation. 2006;82(11):1396–401.
Souter MJ, et al. Organ donor management: part 1. Toward a consensus to guide anesthesia services during donation after brain death. Semin Cardiothorac Vasc Anesth. 2018;22(2):211–22.
Ardehali A, et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015;385(9987):2577–84.
Chan JL, et al. Intermediate outcomes with ex-vivo allograft perfusion for heart transplantation. J Heart Lung Transplant. 2017;36(3):258–63.
Michel SG, et al. Preservation of donor hearts using hypothermic oxygenated perfusion. Ann Transplant. 2014;19:409–16.
Russo MJ, et al. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the united network for organ sharing database. J Thorac Cardiovasc Surg. 2007;133(2):554–9.
Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res. 2009;83(2):247–61.
Marelli D, et al. The use of donor hearts with left ventricular hypertrophy. J Heart Lung Transplant. 2000;19(5):496–503.
Anaya-Prado R, Delgado-Vazquez JA. Scientific basis of organ preservation. Curr Opin Organ Transplant. 2008;13(2):129–34.
Hicks M, et al. Organ preservation. Methods Mol Biol. 2006;333:331–74.
Karmazyn M, et al. The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease. Circ Res. 1999;85(9):777–86.
Vigne P, Frelin C, Lazdunski M. The Na+/H+ exchanger in eukaryotic cells: biochemical and pharmacological properties and physiological role. Biochimie. 1985;67(1):129–35.
Banner NR, et al. The importance of cold and warm cardiac ischemia for survival after heart transplantation. Transplantation. 2008;86(4):542–7.
Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357(11):1121–35.
Morciano G, et al. Mechanistic role of mPTP in ischemia-reperfusion injury. Adv Exp Med Biol. 2017;982:169–89.
Stobierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol. 2001;38(4):923–31.
Patarroyo M, et al. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era. J Heart Lung Transplant. 2012;31(3):282–7.
Chan JL, et al. Vasoplegia after heart transplantation: outcomes at 1 year. Interact Cardiovasc Thorac Surg. 2017;25(2):212–7.
Omar S, Zedan A, Nugent K. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment. Am J Med Sci. 2015;349(1):80–8.
Haddad F, et al. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117(11):1436–48.
Ardehali A, et al. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation. 2001;72(4):638–41.
Argenziano M, et al. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation. 1997;96(9 Suppl):Ii-286–90.
Armitage JM, Hardesty RL, Griffith BP. Prostaglandin E1: an effective treatment of right heart failure after orthotopic heart transplantation. J Heart Transplant. 1987;6(6):348–51.
Auler Junior JO, et al. Low doses of inhaled nitric oxide in heart transplant recipients. J Heart Lung Transplant. 1996;15(5):443–50.
Chen EP, et al. Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. J Heart Lung Transplant. 1998;17(7):669–78.
De Santo LS, et al. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients. Transplant Proc. 2008;40(6):2015–8.
Morales DL, et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg. 2003;75(3):926–30.
Pascual JM, et al. Prostacyclin in the management of pulmonary hypertension after heart transplantation. J Heart Transplant. 1990;9(6):644–51.
Theodoraki K, et al. Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction. Acta Anaesthesiol Scand. 2006;50(10):1213–7.
Taghavi S, et al. Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg. 2004;78(5):1644–9.
Thomas HL, et al. Incidence and outcome of Levitronix CentriMag support as rescue therapy for early cardiac allograft failure: a United Kingdom national study. Eur J Cardiothorac Surg. 2011;40(6):1348–54.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lebeis, T., Lewis, G. (2020). Right Heart Failure After Cardiac Transplantation. In: Tsao, L., Afari, M. (eds) Clinical Cases in Right Heart Failure. Clinical Cases in Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-38662-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-38662-7_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-38661-0
Online ISBN: 978-3-030-38662-7
eBook Packages: MedicineMedicine (R0)